Chaoju Eye Care (2219) Announces Plans for On-Market Share Repurchase

Bulletin Express11-18

Chaoju Eye Care Holdings Limited (2219) announced an intention to repurchase shares on the open market, with a current aggregate purchase limit of up to HK$50 million. According to the announcement, the repurchase may begin on 17 November 2025 and will be conducted under the existing Share Repurchase Mandate approved at the annual general meeting on 6 June 2025.

The company stated that the repurchase’s timing and amount will depend on market conditions, and the maximum aggregate purchase limit may be increased. The announcement clarified that there is no guarantee regarding the timing, quantity, or price of any share repurchases, and investors are advised to exercise caution when dealing in the company’s shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment